Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-18T20:34:14.927Z Has data issue: false hasContentIssue false

The action of 2:4-diamino-6:7-diisopropylpteridine on normal, proguanil- and sulphadiazine-resistant strains of Plasmodium gallinaceum

Published online by Cambridge University Press:  06 April 2009

Elspeth W. McConnachie
Affiliation:
Molteno Institute, University of Cambridge

Extract

1. 2:4-diamino-6:7-diisopropylpteridine has an antimalarial index of 1:40, when tested against Plasmodium gallinaceum.

2. 2:4-diamino-1′-methylindolo-(2′:3′-6:7)-pteridine showed no activity against P. gallinaceum in doses tolerated by the chick.

3. Proguanil- and sulphadiazine-proguanil-resistant strains of P. gallinaceum were cross-resistant to 2:4-diamino-6:7-diphenylpteridine.

4. Proguanil- and sulphadiazine-proguanil-resistant strains of P. gallinaceum showed no cross-resistance to 2:4-diamino-6:7-diisopropylpteridine, but were slightly hypersensitive to this compound.

I wish to thank Dr A. Bishop for her interest in this work, and for advice and criticism. The work has been financed by the Medical Research Council.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1953

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bishop, A. & Birkett, B. (1948). Drug-resistance in Plasmodium gallinaceum, and the persistence of paludrine-resistance after mosquito transmission. Parasitology, 39, 125.Google Scholar
Bishop, A. & McConnachie, E. W. (1948). Resistance to sulphadiazine and ‘paludrine’ in the malaria parasite of the fowl (Plasmodium gallinaceum). Nature, Lond., 162, 541.Google Scholar
Bishop, A. & McConnachie, E. W. (1950). Sulpha-diazine-resistance in Plasmodium gallinaceum and its relation to other antimalarial compounds. Parasitology, 40, 163.Google Scholar
Carrington, H. C., Crowther, A. F., Davey, D. G., Levi, A. A. & Rose, F. L. (1951). A metabolite of ‘paludrine’ with high antimalarial activity. Nature, Lond., 168, 1080.Google Scholar
Collier, H. O. J. & Waterhouse, P. D. (1950 a). Studies in the chemotherapy of cholera. II. In vitro vibrio-static properties of certain 2:4-diamino-pteridines. Ann. Trop. Med. Parasit. 44, 156.Google Scholar
Collier, H. O. J. & Waterhouse, P. D. (1950 b). Studies in the chemotherapy of cholera. IV. Antagonism of the antibacterial activities of 2:4-diamino-pteridines, sulphaguanidine, and their mixtures. Ann. Trop. Med. Parasit. 44, 273.Google Scholar
Collier, H. O. J., Campbell, N. R. & Fitzgerald, M. E. H. (1953). Vibriostatic activity in certain series of pteridines. Nature, Lond., 165, 1004.Google Scholar
Collier, H. O. J., Hall, I. F. & Waterhouse, P. D. (1950). Studies in the chemotherapy of cholera. III. The action of pteridine-sulphonamide mixtures upon Vibrio cholerae and upon the mouse. Ann. Trop. Med. Parasit. 44, 161.CrossRefGoogle ScholarPubMed
Curd, F. H. S., Davey, D. G. & Rose, F. L. (1945). Studies on synthetic antimalarial drugs. I. Biological methods. Ann. Trop. Med. Parasit. 39, 139.Google Scholar
Daniel, L. J. & Norris, L. C. (1947). Growth inhibition of bacteria by synthetic pterins. II. Studies with Escherichia coli, Staphylococcus aureus and Lactobacillus arabinosus showing synergism between pterin and sulfonamide. J. Biol. Chem. 170, 747.CrossRefGoogle Scholar
Daniel, L. J., Norris, L. C., Scott, M. L. & Heuser, G. F. (1947). Growth inhibition of bacteria by synthetic pterins. I. Studies with Streptococcus faecalis, Lactobacillus casei and Lactobacillus arabinosus. J. Biol. Chem. 169, 689.Google Scholar
Falco, E. A., Goodwin, L. G., Hitchtngs, G. H., Rollo, I. M. & Russell, P. B. (1951). 2:4-diamino-pyrimidines—a new series of antimalarials. Brit. J. Pharmacol. 6, 185.Google Scholar
Falco, E. A., Hitchings, G. H., Russell, P. B. & VanderWerff, H. (1949). Antimalarials as antagonists of purines and pteroylglutamic acid. Nature, Lond., 164, 107.Google Scholar
Greenberg, J. (1949 a). The antimalarial activity of 2, 4-diamino-6, 7-diphenylpterin; its potentiation by sulfadiazine and inhibition by pteroylglutamic acid. J. Pharmacol. 97, 484.Google Scholar
Greenberg, J. (1949 b). Hypersensitivity to sulfadiazine of a chlorguanide-resistant strain of Plasmodium gallinaceum. J. Nat. Malaria Soc. 8, 80.Google Scholar
Greenberg, J. (1949 c). Inhibition of the antimalarial activity of chlorguanide by pteroylglutamic acid. Proc. Soc. Exp. Biol., N.Y., 71, 306.Google Scholar
Greenberg, J., Boyd, B. L. & Josephson, E. S. (1948). Synergistic effect of chlorguanide and sulfadiazine against Plasmodium gallinaceum in the chick. J. Pharmacol. 94, 60.Google ScholarPubMed
Greenberg, J. & Richeson, E. M. (1950). Potentiation of the antimalarial activity of sulfadiazine by 2, 4-diamino-5-aryloxypyrimidines. J. Pharmacol. 99, 444.Google Scholar
Greenberg, J. & Richeson, E. M. (1951). Effect of 2, 4-diamino-5-(p−chlorophenoxy)-6-methylpyrimidine and 2, 4-diamino-6, 7-diphenylpteridine on chlorguanide-resistant strain of Plasmodium gallinaceum. Proc. Soc. Exp. Biol., N.Y., 77, 174.Google Scholar
Rollo, I. M. (1951). A 2:4-diaminopyrimidine in the treatment of proguanil-resistant laboratory malarial strains. Nature, Lond., 168, 332.Google Scholar